Filter
404
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
61
New Publications
92
Language
Document type
No document type
188
Guidelines
112
Studies & Reports
40
Manuals
37
Strategic & Response Plan
11
Fact sheets
10
Training Material
4
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
21
Latin America and the Carribbean
10
Africa
10
Global
9
South Africa
8
Ethiopia
5
Germany
5
Western and Central Europe
5
Russia
5
Cameroon
4
Kenya
4
Brazil
4
Burkina Faso
3
Nigeria
3
Zambia
3
Tanzania
3
Rwanda
3
West and Central Africa
3
Eastern Europe
3
Congo-Brazzaville
3
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Uganda
2
Niger
2
Haiti
2
Nepal
2
Bangladesh
2
Malawi
2
Benin
2
Argentina
2
Namibia
2
Eswatini/ Swaziland
2
Ukraine
2
Madagascar
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Venezuela
2
France
2
Sierra Leone
1
USA
1
Togo
1
South Sudan
1
Turkey
1
Syria
1
Gambia
1
Indonesia
1
Peru
1
Burundi
1
Colombia
1
Bolivia
1
Angola
1
Chile
1
Yemen
1
South–East Asia Region
1
Luxembourg
1
Asia
1
Albania
1
Djibouti
1
Laos
1
Canada
1
North America
1
Belgium
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
91
Countries
88
Pharmacy & Technologies
33
Public Health
12
Women & Child Health
12
Key Resources
8
Toolboxes
TB
64
HIV
54
COVID-19
53
AMR
29
NTDs
21
Rapid Response
18
Zika
11
Pharmacy
11
Ebola
9
Refugee
9
Caregiver
7
Polio
5
Cholera
2
Mental Health
2
Global Health Education
2
Planetary Health
2
Natural Hazards
1
Specific Hazards
1
NCDs
1
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés
...
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the
...
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive
...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations
...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommanda
...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14
...
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in
...
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An
...
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
Lignes directrices.
Collection Avis et Rapports.
Interim Technical Note
